Pancreatic β-cells undergo profound hyperplasia during pregnancy to maintain maternal 28 euglycemia. Failure to reprogram β-cells into a more replicative state has been found to underlie 29 susceptibility to gestational diabetes mellitus (GDM). We recently identified a requirement for 30 prolactin receptor (PRLR) signaling in the metabolic adaptations to pregnancy, where mice lacking 31 β-cell PRLR (βPRLRKO) exhibit a metabolic phenotype consistent with GDM. However, the 32 underlying transcriptional program that is responsible for the PRLR-dependent metabolic 33 adaptations during gestation remains incompletely understood. To identify PRLR signaling gene 34 regulatory networks and target genes within β-cells during pregnancy, we performed a 35 transcriptomic analysis of pancreatic islets isolated from either βPRLRKO mice or littermate 36 controls in late gestation. Gene set enrichment analysis identified Forkhead box protein M1 37 (Foxm1) and polycomb repressor complex 2 (PRC2) subunits, Suz12 and Ezh2, as novel candidate 38 regulators of PRLR-dependent β-cell adaptation. GO-term pathway enrichment revealed both 39 established and novel PRLR signaling target genes that together describe a state of increased 40 cellular metabolism and/or proliferation. In contrast to the requirement for β-cell PRLR signaling 41 in maintaining euglycemia during pregnancy, PRLR target genes were not induced following high-42
Introduction 48
Gestational diabetes mellitus (GDM) is a metabolic disorder that emerges only during 49 pregnancy, yet it presents serious health outcomes to mother and offspring even decades after birth 50
(1). As with other forms of diabetes mellitus, a relative deficiency of functional β-cells is a major 51 factor in the pathogenesis of GDM (2). Controversy exists, however, regarding the underlying 52 etiology of GDM when considering its relationship with obesity and nutrition. While glycemic 53 management of GDM can be achieved by nutritional therapy (3), only approximately half of the 54 cases can be attributed to the metabolic effects of obesity (4, 5) . Furthermore, the risk of both 55 recurrent GDM and type 2 diabetes mellitus is exceedingly high and occurs independently of 56 obesity (6) . 57
Unlike various other metabolic stressors that stimulate β-cell expansion, the physiologic 58 adaptation to pregnancy comprises both an interaction between the mother and the feto-placental 59 unit, and a rapidly fluctuating hormonal milieu that induces stereotypic changes in systemic 60 metabolism spanning gestation and postpartum (2). While the proliferative phenotype and 61 augmentation of β-cells seen throughout pregnancy are rapidly reversed postpartum, the adverse 62 consequences of disturbed maternal glucose homeostasis impact both mother and developing 63 offspring during pregnancy and long-term (1,7). These unique features of pregnancy and GDM 64 form the premise for additional studies into the genetic relationship between GDM and type 2 65 diabetes and their shared or distinct pathophysiologic mechanisms (8) . 66
Amongst the diverse extracellular and intracellular mechanisms known to contribute to 67 gestational β-cell adaptation, the lactogens are perhaps the most well-studied (9). Most mammals, 68 including rodents and primates, produce pituitary-derived prolactin and placental lactogens, which 69 both signal through the prolactin receptor (PRLR) (9-12). We and others have established a critical 70 role for PRLR signaling in rodent gestational β-cell proliferation (13), with the lack of PRLR 71 expression in β-cells resulting in a failure of islets to proliferate during gestation (14) . Conversely, 72 β-cell specific overexpression of placental lactogens increases pancreatic islet proliferation and 73 mass (15) . Together these studies illustrate that increases in circulating lactogens during pregnancy 74 are essential and sufficient to orchestrate key components of metabolic adaptations to pregnancy. 75 Downstream targets of PRLR signaling that contribute to gestational proliferation include 76 tryptophan hydroxylase 1 (Tph1), the rate limiting enzyme for islet serotonin synthesis (16), 77 transcription factors such as Foxm1 (17) and MafB (14), osteoprotegerin (Tnfrsf11b), menin 78 (Men1), as well as cyclins, cyclin-dependent kinases, cell cycle inhibitors and Prlr itself (14,16,18-79 20) . However, a global assessment of how PRLR signaling regulates β-cell transcription during 80 gestation is lacking. 81
To address this question, in the current study we examined how loss of PRLR signaling within 82 β-cells alters pancreatic islet gene expression during pregnancy. Our findings identify both known 83 and novel PRLR signaling targets and candidate upstream regulators of β-cell transcription. 84
Additionally, we found that the transcriptomic program driven by PRLR signaling and its target 85 genes is distinct from the compensatory response of islets to high-fat diet feeding, indicating 86 Microarray Analysis. Microarray-based mRNA quantification was performed using the 116 Affymetrix GeneChip Mouse 2.0 Array (ThermoFisher, Waltham, MA US). Hybridization and 117 microarray scanning were performed by the Stanford Functional Genomics Facility (Stanford, 118 CA) . All microarray data have been deposited within the Gene Expression Omnibus repository 119 (GSE118134). Subsequent microarray annotation, normalization, and differential expression 120 analysis were completed in the R statistical computing environment (version 3.4.3). Briefly, raw 121 microarray data across all samples were compiled and corrected using the robust multi-array 122 average (RMA) of background-adjusted and quantile-normalized microarray expression data using 123 R package Oligo (1.42.0) as previously described (21). Gene annotations were then generated 124 using the MoGene-2.0 Transcript Cluster (mogene20sttranscriptcluster.db). Once expression data 125 were examined for RNA quality, the R package limma (version 3.34.9) was used to generate 126 differential gene expression using generalized linear modelling (KO versus WT) with a Benjamini-127 Hochberg (B-H) P-value adjustment (22). Due to sample size limitations (n = 3), dispersion 128 estimates were first determined via maximum likelihood, assuming that genes of similar average 129 expression strength possess similar dispersion, as previously described (23). Gene-wise dispersion 130 estimates were then shrunken according to the empirical Bayes approach, providing normalized 131 count data for genes proportional to both the dispersion and sample size. Differential expression 132 was represented as log2 (fold-change) for each annotated gene. 
Differential gene expression in pancreatic islets from PRLRKO mice during gestation. 167
To identify genes regulated by prolactin receptor (PRLR) signaling in maternal pancreatic 168 islets during pregnancy, we examined global transcriptomic profiles at late gestation using 169 commercial oligonucleotide microarrays (as described in Methods). RNA purified from pancreatic 170 islets isolated from gestational day (GD) 16.5 PRLRKO mice (Prlr f/f ; RIP-Cre) and littermate 171
controls (Prlr f/f and Prlr f/+ ) identified 2,542 differentially-expressed genes (DEGs) at P < 0.05; of 172 these, 70 reached a Bonferroni-adjusted P-value (Q) < 0.05 ( Supplemental Table S2 see (25)). 173
Unsupervised principal components analysis (PCA) revealed that the two eigenvectors most 174 responsible for sample variance (51.7%) were sufficient to describe a separation between 175 PRLRKO mice and controls, supporting that prolactin receptor knockout confers a true and 176 measurable shift in global gene expression (Supplemental Figure S1 ; (26)). Gene set enrichment 177 analysis identified Tryptophan/Serotonin metabolism and Prolactin signaling as enriched 178 pathways ( Fig. 1a) , both of which are associated with the metabolic adaptation to pregnancy 179 (13, 16, 27, 28) . We then compared the DEGs reaching Q-value significance with published studies 180 reporting DEGs in murine islets during pregnancy in wild-type mice. We incorporated microarray 181 diagram of these studies with the 70 DEGs found in PRLRKO mice. This comparison revealed 184 a significant overlap of 26 DEGs (hypergeometric P = 2.8 x 10 -61 ) ( Fig. 1b ). Amongst these were 185 genes responsible for enriching pathways in Fig. 1a including tryptophan metabolism (Tph1,  186 Tph2), and prolactin receptor signaling (Prlr), as well as diverse cellular physiologic processes 187 (Table 1 and (25) Thus, this approach identified 26 genes that are induced by pregnancy in a PRLR-dependent 192 manner. We also mined microarray data of islet gene expression in global PRLR-knockout females 193 (Prlr -/-; created by (39)) examined by Goyvaerts et al. at early gestation (GD9.5) (40). Although 194 the global Prlr -/and PRLRKO models differ in several key respects (9, 14, 39, 41) , this cross-195 model comparison showed a significant overlap (hypergeometric P = 2.9 x 10 -50 ) in differential 196 gene expression (defined as Q < 0.05) ( Fig. 1c ). To further validate our microarray findings, we 197 examined gene expression using qPCR on an independent set of wild-type GD16.5 and 198 nonpregnant C57Bl6/J female mice, which revealed significant changes in expression consistent 199 with array data (Fig. 1d ). Altogether, these results indicate that the effects of PRLR signaling on Our analysis establishes that PRLR signaling is necessary for the induction of a subset of genes 205 in islets during healthy gestation. However, PRLR signaling may itself interact with the hormonal 206 milieu of pregnancy to regulate transcription. To determine whether PRLR signaling is sufficient 207 to regulate genes in an islet-autonomous fashion, we treated cultured islets for 24 hours with 208 recombinant prolactin. This treatment significantly upregulated many of the PRLR-dependent 209 DEGs ( Fig. 2a) , including Tph1 and Tph2 as previously reported (29). Our findings therefore 210 demonstrate that PRLR signaling is both sufficient and required to regulate a subset of DEGs 211 normally induced by pregnancy. 212
Metabolic stressors including nutrition and pregnancy have been theorized to converge on the 213 β-cell, leading to its dysfunction and ultimately diabetes mellitus; however, empirical evidence 214 supporting this mechanistic convergence remain inconclusive (1, 42) . Because pregnancy initiates 215 an adaptive metabolic response via profound increases in lactogenic and other hormones, we 216 hypothesized that PRLR-mediated adaptations activate a pregnancy-specific adaptive mechanism 217 in pancreatic islets. To test this, we first compared our βPRLRKO dataset to published RNA-218 sequencing data of gene expression changes following high-fat diet (HFD), a widely-used 219 metabolic stress model system (43) (Fig. 2b) . Surprisingly, the overlap of DEGs was minimal and 220 not significant (Hypergeometric P = 0.4), comprising only 4 genes (Matn2, 2410021H03Rik, 221
Igfbp5, Cntn3) that were differentially co-expressed by both βPRLRKO and 30-day HFD feeding. 222
As Cruciani et al. only examined male mice (43), we performed a 4-week nutritional study using 223 female mice to determine whether high-fat diet (HFD) feeding displayed sexually dimorphic 224 effects on the 70 DEGs reaching Q-value significance in βPRLRKOs. Consistent with findings in 225 male mice, females exhibited no significant changes in these genes following 4 weeks of high-fat 226 diet (Fig. 2c) . Thus, for both sexes, HFD feeding was incapable of inducing PRLR-dependent 227
DEGs. 228
We next sought to determine whether the PRLR is required for β-cell physiologic adaptation 229 to HFD feeding. Unlike the requirement for intact PRLR signaling in maintaining gestational 230 glucose homeostasis, both PRLRKO female mice and littermate controls had no baseline 231 difference in GTT ( Fig. 2d ) and developed equivalent glucose intolerance following four weeks of 232 HFD feeding ( Fig. 2e) . These results support our hypothesis that both transcriptional regulation 233 and physiologic adaptation of β-cells by PRLR signaling employs pregnancy-specific mechanisms 234 that differ from those of HFD adaptation. 235 236
Pathway analysis of differential gene expression. 237
To identify potential mechanisms underlying pregnancy-specific adaptations in islets, we next 238 sought to understand the global transcriptional landscape that is regulated by PRLR signaling in 239 pregnancy. Because the FDR-adjusted threshold yielded only 70 DEGs, we considered whether 240 reducing the statistical stringency of our analysis (P < 0.05) would capture nodal networks and 241 regulatory clusters. Hierarchical clustering and heatmap visualization justified this approach, 242 displaying a distinct expression profile even at this cutoff (Fig. 3a) . KEGG Pathway enrichment 243 of the 2,540 genes (P < 0.05) revealed a clear signature of cellular proliferation amongst all of the 244 top-5 most enriched networks: G2/M DNA Damage Checkpoint (P = 1.7 x 10 -5 ), GADD45 245 Signaling (P = 5.6 x 10 -5 ), Regulation of Cellular Mechanics (P = 2.3 x 10 -4 ), Estrogen-mediated 246 S-phase Entry (P = 2.8 x 10 -4 ), and Mitotic Roles of Polo-Like Kinase (P = 4.9 x 10 -4 ). Volcano 247 plot revealed a negatively skewed signature of transcriptional changes by βPRLRKO relative to 248 littermate controls (Fig. 3b) , consistent with known upregulation of β-cell genes during pregnancy 249 (30, 31) . 250
Our gene set enrichment analysis identified established pathways differentially affected by loss 251 of PRLR signaling. However, to identify novel networks affected in βPRLRKO, we used the 252 STRING database (44) to generate a network of DEGs based on known and predicted interactions 253 among their encoded proteins (Fig. 3c ). After ranking nodes by degree of interaction, the largest 254 cluster was identified to functionally enrich pathways associated with cellular proliferation and 255 developmental programs ( Fig. 3d ): cell cycle (BH-adjusted P = 10 -9 ), progesterone-mediated 256 oocyte maturation (BH-adjusted P = 10 -6.2 ), p53 signaling (BH-adjusted P = 10 -5.3 ), FoxO signaling 257 novo DNA methylation (46, 47) . Examination of the genes reported to interact with PRLR revealed 273 increased expression of upstream factors and decreased expression of PRLR target genes (Fig. 4b) . 274
Of the PRLR target genes, we noted that the histone methyltransferase Enhancer of Zeste 275 Homologue 2 (Ezh2) was suppressed in βPRLRKO. 276
As a transmembrane receptor resident at the cell surface, PRLR indirectly regulates 277 transcription through signal transduction cascades, including the canonical JAK2-STAT5 pathway 278 (48). However, as mice with a β-cell specific deletion of Stat5 do not exhibit defective glucose 279 homeostasis or GDM during pregnancy (49), we hypothesized that multiple transcription factors 280 coordinately regulate transcription for PRLR signaling-mediated gestational adaptations. To 281 identify candidates, we inspected the proximal promoter region (-1kB to +500kB) of differentially-282 regulated genes (P < 0.05) for disproportionate enrichment of transcription factor binding sites. 283
Using the ENCODE ChIP-sequencing database (50), we identified promoter binding sites for 284
Foxm1 and E2f4 among down-regulated DEGs (Fig. 4c) , a finding consistent with prior studies 285 (14, 17) . Stat5a was also statistically enriched (FDR < 0.05), though not among the 10 most-286 enriched putative regulators. Conversely, promoter enrichment of genes expressed at higher levels 287 in βPRLRKO identified promoter binding sites for Suz12 (BH-adjusted P = 10 -7.8 ) and Ezh2 (BH-288 adjusted P = 10 -4.4 ), two components of the polycomb repressor complex (PRC2) (Fig. 4d ). Co-289 localization of Ezh2 and Suz12 promoter binding sites DEGs was also noted, demonstrating a 90% 290 (28/31) overlap. To determine whether PRC2 methyltransferase activity likely controls gene 291 expression in βPRLRKO, we then enriched DEG promoters using ChIP-sequencing analysis of 292 chromatin modifications using the human histone modification database (51). Histone 293 modification enrichment identified H3K27 trimethylation (H3K27me3), the modification 294 enzymatically mediated by EZH2/PRC2, as the only histone modification localized to up-regulated 295 DEG promoters (Fig. 4e) . Reciprocally, the promoter regions of down-regulated DEGs contained 296 sites of H3K27 acetylation (H3K27ac), the counter-regulatory modification of H3K27me3. 297
Consistent with other research (52,53), these observations support that the PRC2-mediated gene 298 silencing that occurs during pregnancy is de-repressed in the setting of βPRLRKO. 299
Ezh2 has been classically identified as a transcriptional repressor via histone-methyltransferase 300 activity in the PRC2 (54). However, we and others have identified a paradoxical role for Ezh2 as 301 a positive regulator of gene expression upon heterodimerization with Foxm1 and other 302 transcriptional regulators (55-57). Therefore, to understand whether this dual role of Ezh2 might 303 be simultaneously present in pancreatic islets, we plotted the 75 DEGs (P < 0.05) that are targets 304 of Ezh2 according to the Ingenuity® database (Fig. 4f ). The resulting distribution depicted a broad 305 array of target genes both increased and decreased by βPRLRKO. Additionally, genes co-targeted 306 by Ezh2 and Foxm1 feature key regulators of cellular proliferation (Fig. 4g) : Top2a (log2fold = -307 1.4, P = 0.001 ), Mki67 (log2fold = -1.4, P = 0.001), Ccne2 (log2fold = -0.30, P = 0.04), Myc 308 (log2fold = -0.81, P = 0.0007), Esr1 (log2fold = -0.60, P = 0.005), Cdk1 (log2fold = -0.6, P = 309 0.001), and Cdkn1a (log2fold = 0.87, P = 0.0096). In sum, our analyses support a role of Foxm1 310 and Ezh2 as co-regulators of the proliferative signature within β-cells during pregnancy. 311
312
Discussion 313
Prior studies have identified transcriptional changes within pancreatic islets during pregnancy, 314 a period of rapid β-cell proliferation and mass expansion (29-31). Many hormonal and metabolic 315 changes accompany gestation, with lactogens serving a critical role in physiologic adaptation of 316 β-cells (14, 15) . While the mitogenic effects of lactogen signaling have been widely studied, the 317 specific gene targets and transcriptional networks under lactogen control remain poorly 318 understood. Using a β-cell specific prolactin receptor knockout (βPRLRKO) mouse model, we 319 confirm the requirement of intact β-cell PRLR signaling for induction of both well-established and 320 novel genes and gene networks during pregnancy. 321
We identified and cross-validated a number of known and novel pro-proliferative genes as 322 induced by pregnancy in a PRLR-dependent manner (Table 1) . Our findings are consistent with a 323 recent proteomic analysis of islets during pregnancy, which independently found proteins encoded 324 by our DEGs to be differentially regulated in late gestation: Ivd, Matn2, Ehhadh, Myc, and Chgb 325 (32) . Amongst these, we confirmed the requirement of intact β-cell PRLR signaling for induction 326 of well-established gestational pro-proliferative genes (e.g. Tph1, Tph2, Prlr, Opg) . In addition to 327 previously identified genes of pregnancy, we identified many novel gene targets of PRLR 328 signaling that provide exciting avenues for future study into the mechanisms of islet gestational 329 adaptation. For instance, pregnancy increases gap junction coupling between β-cells (11), which 330 has been theorized to regulate insulin secretion and the alterations in insulin secretion during 331 pregnancy (58). Claudin-8 (Cldn8), here identified as induced by PRLR in pregnancy, is an integral 332 membrane protein and tight junction component that has not been studied in β-cells in any context. 333
In our search for regulatory networks impacted by PRLR disruption in pregnancy, we 334 identified Foxm1 and Ezh2 as putative nodal upstream co-regulators of gestational gene expression 335 and cellular proliferation (Fig. 5 ). Within the pancreatic islet, Ezh2 has previously been shown to 336 silence the tumor suppressor Ink4a/Arf (p16) in aging and diabetes to increase β-cell proliferation 337 (59, 60) . Conversely, selective β-cell Ezh2 knockout in mice has been shown to produce 338 hyperglycemia in mice (59). In the current study, we found that pregnancy induces Ezh2 in a 339 PRLR-dependent manner. Therefore, gestational induction of Ezh2 likely creates a pro-340 proliferative state required for metabolic adaptation. Our results thus broaden our understanding 341 of Ezh2 as a regulator of β-cell function. 342
Though canonically associated with gene silencing via histone 3 trimethylation (H3K27me3), 343
Ezh2 has also been shown to heterodimerize with transcription factors, such as Foxm1, to activate 344 gene expression in a methylation-independent mechanism (57,61). In breast and prostate tissue, 345
Ezh2 is induced by PRLR activation via STAT5, and mediates the mitogenic effects of prolactin 346 in these tissues (62,63). Our results therefore support a broader role for Ezh2 in the regulation of 347 β-cell proliferation during pregnancy, analogous to its role in other tissues (57). 348
As GDM and type 2 diabetes share many similarities and risk factors, it has been widely 349 assumed that they share underlying pathophysiologic mechanisms. However, our data demonstrate 350 that the reprogramming of pancreatic islets during pregnancy is distinct from that of nutritional 351 stressors. We found that the robust PRLR-dependent transcriptional changes in gestation were not 352 regulated by HFD feeding. Co-expression network analysis further identified distinct functional 353 enrichment in pregnancy associated with cellular proliferation, whereas HFD feeding enriched 354 fatty acid signaling via PPARs. Our analysis therefore provides several avenues for investigation 355 whereby disease-specificity may be realized. Stable modifications to gene accessibility and 356 expression, termed epigenetic changes, that we have identified as etiology-specific drivers of other 357 diseases (57). Here, we identify many PRLR-dependent epigenetic modifiers that regulate 358 chromatin remodeling (via Ezh2 and Suz12) and/or differential DNA methylation (via Gadd45g 359 and Dnmt3b). Therefore, the pregnancy-specific response to PRLR signaling likely requires many 360 genetic and epigenetic regulators to coordinate β-cell adaptation. Nevertheless, future studies are 361 needed to mechanistically define these programs. 362
While our findings underscore the importance of PRLR signaling as a mediator of β-cell 363 function in pregnancy, we recognize several limitations to our studies. We and others have 364 established that PRLR is expressed specifically in β-cells of rodent islets (14,64). However, we 365 cannot exclude the possibility of non-β-cell effects of βPRLRKO. Therefore, future studies should 366 employ single-cell or cell-sorted approaches to analyze gestational islet transcription. The 367 computational approach we used to define transcriptional regulators of PRLR signaling provide 368 preliminary support for their role in gestational adaptation; however, future mechanistic studies 369 are needed to determine the nature of their influence. Additionally, although gestational induction 370 of DEGs in our data is likely to be directly downstream of PRLR signaling, we recognize that 371 parallel compensatory signaling mechanisms exist which may contribute to the differential 372 regulation of gene expression. Consistent with this possibility, we observed a subtle increase in 373 GHR expression on microarray analysis (1.3-fold, P = 0.03), a known inducer of the prolactin 374 receptor (65). 375
In conclusion, the current study examines novel pregnancy-specific gene networks and PRLR-376 dependent transcriptional programs that describe a state of augmented cellular proliferation. 377
Despite the stated limitations, we believe that the computational approach, combined with both in 378 vivo and in vitro experimentation, serves to significantly advance our understanding of how β-cells 379 respond to the metabolic demands of pregnancy. These lactogen-mediated regulatory networks 380 likely reflect broader adaptive mechanisms that apply to other contexts. We propose PRLR- 
